SAZ.DE - STADA Arzneimittel Aktiengesellschaft

XETRA - XETRA Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures

Market Cap (intraday) 55.24B
Enterprise Value 36.3B
Trailing P/E 61.31
Forward P/E 123.20
PEG Ratio (5 yr expected) 11.57
Price/Sales (ttm)2.27
Price/Book (mrq)5.43
Enterprise Value/Revenue 32.72
Enterprise Value/EBITDA 615.27

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 3.69%
Operating Margin (ttm)12.52%

Management Effectiveness

Return on Assets (ttm)5.45%
Return on Equity (ttm)9.23%

Income Statement

Revenue (ttm)2.31B
Revenue Per Share (ttm)37.17
Quarterly Revenue Growth (yoy)3.10%
Gross Profit (ttm)1.14B
EBITDA 412.69M
Net Income Avi to Common (ttm)85.32M
Diluted EPS (ttm)1.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)252.3M
Total Cash Per Share (mrq)4.05
Total Debt (mrq)1.32B
Total Debt/Equity (mrq)130.78
Current Ratio (mrq)0.65
Book Value Per Share (mrq)15.46

Cash Flow Statement

Operating Cash Flow (ttm)262.88M
Levered Free Cash Flow (ttm)166.54M

Trading Information

Stock Price History

Beta 1.28
52-Week Change 329.94%
S&P500 52-Week Change 313.44%
52 Week High 390.24
52 Week Low 356.51
50-Day Moving Average 384.54
200-Day Moving Average 384.58

Share Statistics

Avg Vol (3 month) 351.43k
Avg Vol (10 day) 330.62k
Shares Outstanding 562.26M
Float 12.03M
% Held by Insiders 164.50%
% Held by Institutions 122.26%
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 40.72
Forward Annual Dividend Yield 40.86%
Trailing Annual Dividend Rate 30.11
Trailing Annual Dividend Yield 30.13%
5 Year Average Dividend Yield 4N/A
Payout Ratio 452.55%
Dividend Date 3N/A
Ex-Dividend Date 4Aug 31, 2017
Last Split Factor (new per old) 22/1
Last Split Date 3Aug 2, 2004